Live market news
Stocks
CHRN

ChronoScale Corporation

CHRNStockUSA

See in Charts

Latest news on CHRNranked by Oyticker for market impact

72Impact
PositiveMajor information1 Oct 2026 · 21:40 UTC · Global · Medium term
ChronoScale reaches $1B contracted run-rate revenue; divests Ekso Bionics unit
ChronoScale announced expanded customer agreements reaching $1B in contracted run-rate revenue and a separate sale of its Ekso Bionics business unit, signaling portfolio focus on AI infrastructure.
CHRNSemiconductorsArtificial intelligenceCloud InfrastructureTechnology

SEC filings

What CHRN filed

All its filings

6 Nov 2026
Shareholder vote results (opens the document on sec.gov)8-K
15 Oct 2026
Results announced (opens the document on sec.gov)8-K
14 Oct 2026
Quarterly report (opens the document on sec.gov)10-Q
6 Oct 2026
Executive or director change (opens the document on sec.gov)8-K
2 Oct 2026
Executive or director change (opens the document on sec.gov)8-K
Bylaws or fiscal year changed · Investor communication
25 Sept 2026
Proxy statement (opens the document on sec.gov)DEF 14A
16 Sept 2026
Material agreement (opens the document on sec.gov)8-K
27 Aug 2026
Investor communication (opens the document on sec.gov)8-K
Other event
19 Aug 2026
Annual report (opens the document on sec.gov)10-K
18 Aug 2026
Executive or director change (opens the document on sec.gov)8-K
30 Jun 2026
Other event, amended (opens the document on sec.gov)8-K/A
30 Jun 2026
Executive or director change (opens the document on sec.gov)8-K
Other event
26 Jun 2026
Material agreement (opens the document on sec.gov)8-K
New debt or obligation
4 Jun 2026
Restructuring costs (opens the document on sec.gov)8-K
20 May 2026
Executive or director change, amended (opens the document on sec.gov)8-K/A

From SEC EDGAR, the public record of what US-listed companies file. Each document opens on sec.gov.

Oyticker provides market information and analysis for educational purposes. It is not investment advice: you remain responsible for your own decisions.

Latest news on CHRNranked by Oyticker for market impact

ChronoScale reaches $1B contracted run-rate revenue; divests Ekso Bionics unit

What CHRN filed